Persistent Systems and NVIDIA Unite to Revolutionize AI-Driven Drug Discovery in Healthcare

March 17, 2026
Persistent Systems and NVIDIA Unite to Revolutionize AI-Driven Drug Discovery in Healthcare
  • Persistent Systems and NVIDIA are joining forces to accelerate AI-powered drug discovery in Healthcare and Life Sciences, leveraging NVIDIA's full-stack AI platform and GenMolVS for generative molecules and virtual screening.

  • The collaboration aims to de-risk early discovery, speed up experimentation, and improve downstream clinical development success through high-fidelity simulations and scalable, cost-effective AI workloads.

  • Persistent plans to enhance the effort with NVIDIA Nemotron open models and deploy production-grade AI applications using NVIDIA AI Enterprise, accelerated compute, servers, and NIM microservices.

  • In Q3 FY2025-2026, Persistent Systems reported consolidated revenue of ₹3,818.70 crore, up 22.99% year over year, and a net profit of ₹439.45 crore, up 17.82% year over year.

  • Regulatory notes include minor US tax penalties in Kansas and Alabama, a disclosed cyber negligence lawsuit tied to a former employee’s alleged blackmail, and a stock-exchange warning about delayed disclosure of a senior management resignation.

  • Forward-looking statements carry risk, with full details disclosed in Persistent’s FLCS.

  • Persistent’s stock dipped about 2.6% on the announcement, with past-year underperformance but mixed analyst ratings and potential upside based on consensus targets.

  • The company plans investor and analyst sessions on March 19-20, 2026 with select institutions, conducted under SEBI Regulation 30 and based on the Q3 FY26 earnings call, without sharing unpublished price-sensitive information.

  • HLS is a fast-growing segment, contributing roughly one-third of FY2025 revenue of ₹11,940 crore, driven by digital health initiatives and data-driven healthcare solutions.

  • Sessions will be held both virtually and in person, with one-on-one meetings and formal notifications to exchanges signed by the Company Secretary.

  • For shareholders, the alliance signals a move toward a high-growth, AI-enabled healthcare market with potential new revenue streams and expanded services.

  • Persistent is a global AI-led digital engineering and modernization company with 26,500+ employees, certifications, sustainability and inclusion recognition, and ongoing carbon-neutrality efforts.

Summary based on 8 sources


Get a daily email with more AI stories

More Stories